This statistic displays the global respiratory therapy market by condition based on the MAT ( moving annual total ) until the third quarter of 2018 ( October 2017 to September 2018 ) . In that year , the global asthma therapy market generated 20.5 billion U.S. dollars . Asthma is a major cause of morbidity and mortality globally and it is thought to have become more prevalent in the last decades . Fixed combination doses of preventative and symptomatic treatments are used to combat moderate to severe asthma .
